Eunju Park

Prof. Eunju Park

Hallym University
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 January 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
JJJin-Ju Jeong
Jin-Ju Jeong
HPHee Jin Park
Hee Jin Park
MCMin Gi Cha
Min Gi Cha
EPEunju Park
Eunju Park
SWSung-min Won
Sung-min Won
KSKi Tae Suk
Ki Tae Suk
Over the past decade, scientific evidence for the properties, functions, and beneficial effects of probiotics for humans has continued to accumulate. Interest in the use of probiotics for humans has increased tremendously. Among various microorganisms, probiotics using bacteria have been widely studied and commercialized, and, among them, Lactobacillus is representative. This genus contains about 300 species of bacteria (recently differentiated into 23 genera) and countless strains have been reported. They improved a wide range of diseases including liver disease, gastrointestinal diseases, respiratory diseases, and autoimmune diseases. Here, we intend to discuss in depth the genus Lactobacillus as a representative probiotic for chronic liver diseases.

25 February 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
HGHaripriya Gupta
Haripriya Gupta
BMByeong-Hyun Min
Byeong-Hyun Min
Raja GanesanRaja Ganesan
Raja Ganesan
YGYoseph Asmelash Gebru
Yoseph Asmelash Gebru
SSSatya Priya Sharma
Satya Priya Sharma
KSKi Tae Suk
Ki Tae Suk
Non-alcoholic fatty liver disease (NAFLD) is considered to be a significant health threat globally, and has attracted growing concern in the research field of liver diseases. NAFLD comprises multifarious fatty degenerative disorders in the liver, including simple steatosis, steatohepatitis and fibrosis. The fundamental pathophysiology of NAFLD is complex and multifactor-driven. In addition to viruses, metabolic syndrome and alcohol, evidence has recently indicated that the microbiome is related to the development and progression of NAFLD. In this review, we summarize the possible microbiota-based therapeutic approaches and highlight the importance of establishing the diagnosis of NAFLD through the different spectra of the disease via the gut–liver axis.

Verified
Journal Article
Open access
PDF file
YGYoseph Asmelash Gebru
Yoseph Asmelash Gebru
HGHaripriya Gupta
Haripriya Gupta
HKHyeong Seop Kim
Hyeong Seop Kim
JEJung A. Eom
Jung A. Eom
KHKwon Goo Hyun
Kwon Goo Hyun
KSKi Tae Suk
Ki Tae Suk
Nonalcoholic fatty liver disease (NAFLD) is a condition characterized by hepatic accumulation of excess lipids. T cells are commonly classified into various subsets based on their surface markers including T cell receptors, type of antigen presentation and pathophysiological functions. Several studies have implicated various T cell subsets and natural killer (NK) cells in the progression of NAFLD. While NK cells are mainly components of the innate hepatic immune system, the majority of T cell subsets can be part of both the adaptive and innate systems. Several studies have reported that various stages of NAFLD are accompanied by the accumulation of distinct T cell subsets and NK cells with different functions and phenotypes observed usually resulting in proinflammatory effects. More importantly, the overall stimulation of the intrahepatic T cell subsets is directly influenced by the homeostasis of the gut microbiota. Similarly, NK cells have been found to accumulate in the liver in response to pathogens and tumors. In this review, we discussed the nature and pathophysiological roles of T cell subsets including γδ T cells, NKT cells, Mucosal-associated invariant T (MAIT) cells as well as NK cells in NAFLD.

Verified
Journal Article
Open access
PDF file
SWSung-Min Won
Sung-Min Won
EPEunju Park
Eunju Park
JJJin-Ju Jeong
Jin-Ju Jeong
Raja GanesanRaja Ganesan
Raja Ganesan
HGHaripriya Gupta
Haripriya Gupta
KSKi Tae Suk
Ki Tae Suk
In chronic liver disease, the causative factor is important; however, recently, the intestinal microbiome has been associated with the progression of chronic liver disease and the occurrence of side effects. The immune system is affected by the metabolites of the microbiome, and diet is the primary regulator of the microbiota composition and function in the gut–liver axis. These metabolites can be used as therapeutic material, and postbiotics, in the future, can increase or decrease human immunity by modulating inflammation and immune reactions. Therefore, the excessive intake of nutrients and the lack of nutrition have important effects on immunity and inflammation. Evidence has been published indicating that microbiome-induced chronic inflammation and the consequent immune dysregulation affect the development of chronic liver disease. In this research paper, we discuss the overall trend of microbiome-derived substances related to immunity and the future research directions.

2 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
EPEunju Park
Eunju Park
JJJin-Ju Jeong
Jin-Ju Jeong
SWSung-min Won
Sung-min Won
SSSatya Priya Sharma
Satya Priya Sharma
YGYoseph Asmelash Gebru
Yoseph Asmelash Gebru
Dong Joon KimDong Joon Kim
Dong Joon Kim
Nonalcoholic fatty liver disease (NAFLD) is one of the most common and increasing liver diseases worldwide. NAFLD is a term that involves a variety of conditions such as fatty liver, steatohepatitis, or fibrosis. Gut microbiota and its products have been extensively studied because of a close relation between NAFLD and microbiota in pathogenesis. In the progression of NAFLD, various microbiota-related molecular and cellular mechanisms, including dysbiosis, leaky bowel, endotoxin, bile acids enterohepatic circulation, metabolites, or alcohol-producing microbiota, are involved. Currently, diagnosis and treatment techniques using these mechanisms are being developed. In this review, we will introduce the microbiota-related mechanisms in the progression of NAFLD and future directions will be discussed.

Verified
Journal Article
Open access
PDF file
JEJung A Eom
Jung A Eom
KHKwon Goo Hyun
Kwon Goo Hyun
NKNa Yeon Kim
Na Yeon Kim
EPEunju Park
Eunju Park
SWSung Min Won
Sung Min Won
KSKi Tae Suk
Ki Tae Suk
The gut microbiota has been known to modulate the immune responses in chronic liver diseases. Recent evidence suggests that effects of dietary foods on health care and human diseases are related to both the immune reaction and the microbiome. The gut-microbiome and intestinal immune system play a central role in the control of bacterial translocation-induced liver disease. Dysbiosis, small intestinal bacterial overgrowth, translocation, endotoxemia, and the direct effects of metabolites are the main events in the gut-liver axis, and immune responses act on every pathways of chronic liver disease. Microbiome-derived metabolites or bacteria themselves regulate immune cell functions such as recognition or activation of receptors, the control of gene expression by epigenetic change, activation of immune cells, and the integration of cellular metabolism. Here, we reviewed recent reports about the immunologic role of gut microbiotas in liver disease, highlighting the role of diet in chronic liver disease.